Credit Suisse’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $566K | Buy |
35,958
+1,027
| +3% | +$16.2K | ﹤0.01% | 2577 |
|
|
2023
Q4 | $563K | Sell |
34,931
-7,979
| -19% | -$129K | ﹤0.01% | 2668 |
|
|
2023
Q3 | $546K | Sell |
42,910
-18,807
| -30% | -$239K | ﹤0.01% | 2626 |
|
|
2023
Q2 | $869K | Buy |
61,717
+12,954
| +27% | +$182K | ﹤0.01% | 2468 |
|
|
2023
Q1 | $753K | Buy |
48,763
+13,031
| +36% | +$201K | ﹤0.01% | 2475 |
|
|
2022
Q4 | $586K | Buy |
35,732
+159
| +0.4% | +$2.61K | ﹤0.01% | 2672 |
|
|
2022
Q3 | $658K | Buy |
35,573
+227
| +0.6% | +$4.2K | ﹤0.01% | 2605 |
|
|
2022
Q2 | $466K | Sell |
35,346
-1,227
| -3% | -$16.2K | ﹤0.01% | 2872 |
|
|
2022
Q1 | $339K | Buy |
36,573
+1,598
| +5% | +$14.8K | ﹤0.01% | 3152 |
|
|
2021
Q4 | $341K | Buy |
34,975
+404
| +1% | +$3.94K | ﹤0.01% | 3245 |
|
|
2021
Q3 | $1.18M | Buy |
34,571
+2,353
| +7% | +$80K | ﹤0.01% | 2471 |
|
|
2021
Q2 | $1.18M | Buy |
32,218
+3,267
| +11% | +$120K | ﹤0.01% | 2521 |
|
|
2021
Q1 | $1.3M | Sell |
28,951
-42,057
| -59% | -$1.88M | ﹤0.01% | 2419 |
|
|
2020
Q4 | $4.05M | Buy |
71,008
+9,124
| +15% | +$521K | ﹤0.01% | 1671 |
|
|
2020
Q3 | $3.18M | Sell |
61,884
-11,537
| -16% | -$592K | ﹤0.01% | 1539 |
|
|
2020
Q2 | $4.39M | Buy |
73,421
+53,045
| +260% | +$3.17M | ﹤0.01% | 1359 |
|
|
2020
Q1 | $839K | Sell |
20,376
-9,566
| -32% | -$394K | ﹤0.01% | 2239 |
|
|
2019
Q4 | $1.86M | Buy |
29,942
+15,635
| +109% | +$973K | ﹤0.01% | 2081 |
|
|
2019
Q3 | $486K | Buy |
+14,307
| New | +$486K | ﹤0.01% | 2819 |
|
|
2018
Q3 | – | Sell |
-5,863
| Closed | -$230K | – | 3456 |
|
|
2018
Q2 | $230K | Buy |
+5,863
| New | +$230K | ﹤0.01% | 3258 |
|